Matthias Götberg
1 – 10 of 104
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Deferral of left main coronary artery revascularization via IVUS or coronary physiology - Long-term outcomes from the SWEDEHEART registry
- Contribution to journal › Article
-
Mark
Cost-effectiveness analysis of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at low risk of surgical mortality in Sweden
- Contribution to journal › Article
-
Mark
Long-Term Clinical Outcomes After IFR- vs FFR-Guided Coronary Revascularization : Insights From the SWEDEHEART National Registry
- Contribution to journal › Article
-
Mark
A Vessel-Specific Analysis of Deferred Lesions Using the Instantaneous Wave-Free Ratio and Fractional Flow Reserve
- Contribution to journal › Article
- 2024
-
Mark
Impact of the COVID-19 Pandemic on Global TAVR Activity: The COVID-TAVI Study
- Contribution to journal › Article
-
Mark
ACURATE neo2 Transcatheter aortic valve implantation without balloon aortic valvuloplasty : direct ACURATE neo2
- Contribution to journal › Article
-
Mark
Outcomes and performance of the ACURATE neo2 transcatheter heart valve in clinical practice : one-yearresults of the ACURATE neo2 PMCF Study
(2024) In EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 20(1). p.85-94
- Contribution to journal › Article
-
Mark
Characteristics and Outcomes of Patients Receiving a Second Rescue Valve During Transcatheter Aortic Valve Implantation
- Contribution to journal › Article
-
Mark
Drug-Coated Balloons Versus Drug-Eluting Stents or Plain Old Balloon Angioplasty : A Long-Term in-Stent Restenosis Study
- Contribution to journal › Article
-
Mark
Bivalirudin versus heparin in ST and non-ST-segment elevation myocardial infarction—Outcomes at two years
- Contribution to journal › Article
